These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


236 related items for PubMed ID: 22981800

  • 1. The effect of TLR4/7 on the TGF-β-induced Smad signal transduction pathway in human keloid.
    Chen J, Zeng B, Yao H, Xu J.
    Burns; 2013 May; 39(3):465-72. PubMed ID: 22981800
    [Abstract] [Full Text] [Related]

  • 2. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    Wu CS, Wu PH, Fang AH, Lan CC.
    Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
    [Abstract] [Full Text] [Related]

  • 3. [Effects of interferon-gamma on the transforming growth factor beta/Smad pathway in keloid-derived fibroblasts].
    Liu JQ, Hu DH, Zhang ZF, Guan H, She T, Zhang J, Bai XZ.
    Zhonghua Shao Shang Za Zhi; 2009 Dec; 25(6):454-9. PubMed ID: 20193171
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
    He S, Liu X, Yang Y, Huang W, Xu S, Yang S, Zhang X, Roberts MS.
    Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression.
    Chua AW, Gan SU, Ting Y, Fu Z, Lim CK, Song C, Sabapathy K, Phan TT.
    J Dermatol Sci; 2011 Dec; 64(3):199-209. PubMed ID: 22005028
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
    Miao Y, Zhang W, Zhong M, Ma X, Qi TG, Sun H.
    Zhonghua Yi Xue Za Zhi; 2007 Feb 06; 87(6):366-70. PubMed ID: 17456374
    [Abstract] [Full Text] [Related]

  • 15. Knockdown of FOXM1 inhibits activation of keloid fibroblasts and extracellular matrix production via inhibition of TGF-β1/Smad pathway.
    Zhang Y, Cheng C, Wang S, Xu M, Zhang D, Zeng W.
    Life Sci; 2019 Sep 01; 232():116637. PubMed ID: 31288014
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Suppression of TGF-β1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid.
    Hsu YC, Chen MJ, Yu YM, Ko SY, Chang CC.
    Arch Dermatol Res; 2010 Dec 01; 302(10):717-24. PubMed ID: 20717830
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK, Bhattacharyya S, Lakos G, Chen SJ, Mori Y, Varga J.
    Arthritis Rheum; 2004 Apr 01; 50(4):1305-18. PubMed ID: 15077315
    [Abstract] [Full Text] [Related]

  • 20. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
    Zhang ZF, Zhang YG, Hu DH, Shi JH, Liu JQ, Zhao ZT, Wang HT, Bai XZ, Cai WX, Zhu HY, Tang CW.
    Burns; 2011 Jun 01; 37(4):665-72. PubMed ID: 21236582
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.